Company Filing History:
Years Active: 2009-2011
Title: David Onyabe: Innovator in Vaccine Technology
Introduction
David Onyabe, an accomplished inventor based in Poolesville, MD, has made significant contributions to the field of biotechnology, particularly in vaccine development. With two patents to his name, his work is paving the way for advancements in the production of recombinant double-stranded RNA nucleocapsids and innovative immunogens.
Latest Patents
David Onyabe's notable patents include:
1. Bacterial packaging strains useful for the generation and production of recombinant double-stranded RNA nucleocapsids and uses thereof. This patent describes bacterial packaging strains that facilitate the production of RNA encoding vaccine antigens, bioactive proteins, and more in eukaryotic cells. The strains enable the packaging of recombinant ssRNA to form rdsRNs from scratch.
2. Webbed immunogens comprising recombinant human immunodeficiency virus (HIV) envelope glycoproteins and the M9 scorpion toxin. This patent discusses HIV envelope immunogens that display multivalent epitopes, resulting in aggregated webbed structures that stabilize native envelope structures through interactions with M9 scorpion toxin derivatives.
Career Highlights
David Onyabe works at the Aeras Global TB Vaccine Foundation, where he applies his innovative expertise to tackle global health issues, particularly in tuberculosis vaccination. His research has the potential to transform how vaccines are developed and produced, focusing on efficacy and safety.
Collaborations
Throughout his career, David has collaborated with other esteemed professionals such as David M. Hone and John Fulkerson. These partnerships have enhanced the richness of his research, contributing to groundbreaking advancements in vaccine technology.
Conclusion
David Onyabe's contributions to biotechnology and vaccine development illustrate the impact of innovation on global health. With his cutting-edge patents and collaborative efforts, he continues to lead the charge in the fight against infectious diseases, marking him as a key figure in the field of medical research.